Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH
Article in Life Sciences (February 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Life Sciences (February 2024)
Article in Redox Biology (February 2024)
Article in International Journal of Chronic Obstructive Pulmonary Disease (December 2023)